NAV
14.10(-1.13%)Fund Size (CR)
₹409.43Expense Ratio
0.66Scheme Type
Active FundValue Research
Min. investment
₹500Minimum Additional Investment
₹500Minimum SIP Investment
₹100Minimum Withdrawal
₹500Exit Load
1%Return Since Launch
25.67%
- 3M
- 6M
- 1Y
- 3Y
- All
Basic Details
Scheme Manager
Ramesh Mantri
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 19 August 2025 | 9852.16 | -1.48% | - | -0.99% | 645/912 |
| 1 Month | 25 July 2025 | 9835.17 | -1.65% | - | -0.39% | 579/904 |
| 3 Month | 26 May 2025 | 10728.20 | 7.28% | - | 1.96% | 83/872 |
| 6 Month | 25 February 2025 | 11565.16 | 15.65% | - | 13.11% | 235/840 |
| 1 Year | 26 August 2024 | 11453.70 | 14.54% | 14.54% | -1.53% | 13/721 |
| 3 Year | - | - | 0% | - | 19.16% | -/- |
| 5 Year | - | - | 0% | - | 21.99% | -/- |
| Since Inception | 6 February 2024 | 14261.00 | 42.61% | 25.67% | 13.11% | 51/906 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 2 September 2024 | 1,20,000 | 127926.75 | 6.61% | 6.61% |
| 3 Year | - | - | - | - | - |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
- Investment type
- Scheme based
- SIP
- Lumpsum
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
5.06%
Standard Deviation
0.80%
Beta
1.21%
Sharpe Ratio
0.11%
Treynor's Ratio
18.59%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Max Healthcare | 7.70% | 253152 | 31.54 | Equity | Healthcare |
| Sun Pharma.Inds. | 6.64% | 159253 | 27.18 | Equity | Pharmaceuticals |
| Fortis Health. | 5.33% | 254578 | 21.83 | Equity | Healthcare |
| Cipla | 4.78% | 125936 | 19.58 | Equity | Pharmaceuticals |
| J B Chemicals & | 4.59% | 106143 | 18.78 | Equity | Pharmaceuticals |
| Laurus Labs | 4.44% | 207928 | 18.18 | Equity | Pharmaceuticals |
| Divi's Lab. | 4.24% | 26326 | 17.36 | Equity | Pharmaceuticals |
| Krishna Institu. | 3.88% | 211597 | 15.90 | Equity | Healthcare |
| Anthem Bioscienc | 3.25% | 175448 | 13.32 | Equity | Pharmaceuticals |
| Apollo Hospitals | 2.93% | 15985 | 11.99 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| WhiteOak Capital Pharma and Healthcare Fund-Dir (G) | 409.43 | -1.65% | 7.28% | 15.65% | 14.54% | - | |
| Nippon India Taiwan Equity Fund - Direct (G) | 351.43 | 12.80% | 30.88% | 31.11% | 35.15% | 26.98% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 351.43 | 12.80% | 30.88% | 31.11% | 35.15% | 26.98% | |
| Aditya Birla SL International Equity Fund - Direct (G) | 229.26 | 3.84% | 12.05% | 15.33% | 25.04% | 14.74% | |
| Aditya Birla SL International Equity Fund - Direct (IDCW) | 229.26 | 3.84% | 12.05% | 15.33% | 25.04% | 14.74% | |
| DSP Banking & Financial Services Fund - Dir (G) | 1346.44 | -2.49% | -1.63% | 13.38% | 16.02% | - |
List of Schemes under WhiteOak Capital Mutual Fund
News
WhiteOak Capital Mutual Fund announces change in Key Personnel
WhiteOak Capital Mutual Fund has announced that Mr. Siddhartha Chaturvedi has been appointed as a Chief Information Security Officer on the Board of the Trustee Company with effect from July 01, 2025.Details of Mr. Siddhartha Chaturvedi
Age: 43
Designation: Chief Information Security Officer
Qualification : B.Tech. ' Information Technology, CISA, CEH, CND, CCNA (S & R), CCNA (Security), ITIL Foundation, RBI Certified Cyber Security Professional (Under AVTU) Mission, ISEA Certified Cyber Hygiene Practitioner from MeITY
Experience: 16
Powered by Capital Market - Live News
WhiteOak Capital Mutual Fund announces change in fund manager under its schemes
WhiteOak Capital Mutual Fund has announced change in fund manager under the following schemes, with effect from 20 May 2025.Change in Fund Manager:
Name of the Scheme Existing Fund Manager(s) Revised Fund Manager(s) WhiteOak Capital Special Opportunities Fund ' Mr. Dheeresh Pathak (Equity)
' Ms. Trupti Agrawal (Equity)
' Mr. Piyush Baranwal (Debt)
' Mr. Ashish Agrawal (Arbitrage)' Mr. Dheeresh Pathak (Equity)
' Ms. Trupti Agrawal (Equity)
' Mr. Piyush Baranwal (Debt)
' Mr. Ashish Agrawal (Arbitrage)
' Mr. Ramesh Mantri (Equity) (Addition)WhiteOak Capital Pharma and Healthcare Fund ' Mr. Ramesh Mantri (Equity)
' Mr. Dheeresh Pathak (Equity)
' Mr. Piyush Baranwal (Debt)
' Mr. Ashish Agrawal (Arbitrage)' Mr. Ramesh Mantri (Equity)
' Mr. Dheeresh Pathak (Equity)
' Mr. Piyush Baranwal (Debt)
' Mr. Ashish Agrawal (Arbitrage)
' Ms. Trupti Agrawal (Equity) (Addition)WhiteOak Capital Multi Asset Allocation Fund ' Mr. Ramesh Mantri (Equity)
' Mr. Dheeresh Pathak (Equity)
' Mr. Piyush Baranwal (Debt)
' Mr. Ashish Agrawal (Arbitrage)' Mr. Ramesh Mantri (Equity)
' Mr. Dheeresh Pathak (Equity)
' Mr. Piyush Baranwal (Debt)
' Mr. Ashish Agrawal (Arbitrage)
' Ms. Trupti Agrawal (Equity) (Addition)Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
16 January 2024
Total AUM (Cr)
₹409.43
WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, WhiteOak Capital Mutual Fund. Launched in 16 January 2024, this fund is managed by Ramesh Mantri. With assets under management (AUM) worth ₹409.43 (Cr), as of 28 August 2025, WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 25.67% since its launch.
The current NAV of WhiteOak Capital Pharma and Healthcare Fund-Dir (G) is ₹14.1, as on 28 August 2025. The fund's benchmark index is BSE Healthcare TRI. You can invest in WhiteOak Capital Pharma and Healthcare Fund-Dir (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹100 while the minimum lumpsum investment is ₹500.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
In respect of each purchase / switch-in of Units, an Exit Load of 1.00% is payable if Units are redeemed / switched-out within 1 month from the date of allotment. No Exit Load is payable if Units are redeemed / switched-out after 1 month from the date of allotment. The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 91.74% in Equity, 5.33% in Debt and 2.93% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 58.84% in Pharmaceuticals & Biotech, 29.35% in Healthcare Services, 5.33% in Debt, 2.93% in Cash & Others, 1.58% in Chemicals & Petrochemical